SYNLAB AG

SYNLAB AG

Information on First Quotation

Description:
New Company (Regulated Market)
Transparency Standard on First Quotation:
Prime Standard
Transaction Type:
New Issue
Supersector:
Pharma & Healthcare
Sector:
Pharma & Healthcare
Subsector:
Health Care
Country:
Germany
Symbol:
SYAB
First Trading Day:
30 Apr 2021
ISIN:
DE000A2TSL71
Class:
Bearer shares without par value
Offering Period:
19 Apr 2021 - 27 Apr 2021
Issuing Method:
Bookbuilding Procedure
Bookbuilding Range:
€ 18.00 - 23.00
Subscription Price:
€ 18.00
First Price:
€ 18.00
Leading Underwriter:
Goldman Sachs, J.P. Morgan
Underwriter:

Joint Global Coordinators & Joint Bookrunners:
Goldman Sachs, J.P. Morgan

Joint Bookrunners:
BofA Securities, Deutsche Bank, Barclays, BNP PARIBAS, HSBC, Jefferies, UniCredit Bank AG

Co-Lead Managers:
Crédit Agricole CIB, Natixis

Independent advisor:
Lilja & Co.

Placement Volume excl. Greenshoe:
€ 671,799,996.00
Placement Volume in Shares excl. Greenshoe:
37,322,222
Placement Volume incl. Greenshoe:
€ 754,437,942.00
Placement Volume of Executed Greenshoe:
€ 82,637,946.00
Placement Volume of New Shares:
22,222,222
Placement Volume of Existing Shares:
19,690,997
Greenshoe in Shares:
5,600,000
Greenshoe Executed in Shares:
4,590,997
Priority Allocation:

None

Allocation friends & family:
0.00 %
Capital Stock / Shares on First Quotation:
222,222,222
Total Market Cap on First Quotation:
€ 4,000,000,000.00
Market Cap (Free Float) on First Quotation:
€ 1,412,000,000.00
Free Float on First Quotation:
35.30 %
Change First Price compared to Issuing Price:
0.00 %
Further Information:

- The Offering comprises up to 22.2 million newly issued ordinary bearer shares from a capital increase as well as 27.5 million ordinary bearer shares from the Pre-IPO shareholders. Cinven, Novo Holdings and Ontario Teachers' Pension Plan Board (together the "Institutional Shareholders") can additionally place up to 12.4 million ordinary bearer shares as an upsize option, subject to market demand. J.P. Morgan as Joint Global Coordinators on the date of pricing. In addition, the Institutional Shareholders will grant a Greenshoe option over 9.3 million ordinary bearer shares to cover possible over-allotments.

- On 12 May 2021, the stabilization manager had partially exercised the greenshoe option granted by the selling shareholders in connection with over-allotments for 4,590,997 ordinary bearer shares with no-par value of Synlab AG at the offer price of EUR 18.00 per share.

Number of Shares in Lockup Period

MonthsShares
6174,709,003

Shareholder Structure on First Quotation

NameBefore IPOAfter IPO
Cinven (Luxco 1) S.A.55.00 %37.90 %
Novo Nordisk Foundation21.30 %14.90 %
Ontario Teachers' Pension Plan Board10.50 %7.30 %
Dr. Bartl Wimmer6.10 %4.60 %
Free Float0.00 %35.30 %

Company Data

Market Status

XETR

-

-

Parts of the trading system are currently experiencing technical issues

The trading system is currently experiencing technical issues

Xetra newsboard

The market status window is an indication regarding the current technical availability of the trading system. It indicates whether news board messages regarding current technical issues of the trading system have been published or will be published shortly.

We strongly recommend not to take any decisions based on the indications in the market status window but to always check the production news board for comprehensive information on an incident.

An instant update of the Market Status requires an enabled up-to date Java™ version within the browser.